The ACRX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ACRX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ACRX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ACRX Detailed Price Forecast - CNN Money||View ACRX Detailed Summary - Google Finance|
|View ACRX Detailed Summary - Yahoo! Finance||View ACRX Stock Research & Analysis - Zacks.com|
|View ACRX Trends & Analysis - Trade-Ideas||View ACRX Major Holders - Barrons|
|View ACRX Call Transcripts - NASDAQ||View ACRX Breaking News & Analysis - Seeking Alpha|
|View ACRX Annual Report - CompanySpotlight.com||View ACRX OTC Short Report - OTCShortReport.com|
|View ACRX Fundamentals - TradeKing||View ACRX SEC Filings - Bar Chart|
|View Historical Prices for ACRX - The WSJ||View Performance/Total Return for ACRX - Morningstar|
|View the Analyst Estimates for ACRX - MarketWatch||View the Earnings History for ACRX - CNBC|
|View the ACRX Earnings - StockMarketWatch||View ACRX Buy or Sell Recommendations - MacroAxis|
|View the ACRX Bullish Patterns - American Bulls||View ACRX Short Pain Metrics - ShortPainBot.com|
|View ACRX Stock Mentions - StockTwits||View ACRX Stock Mentions - PennyStockTweets|
|View ACRX Stock Mentions - Twitter||View ACRX Investment Forum News - Investor Hub|
|View ACRX Stock Mentions - Yahoo! Message Board||View ACRX Stock Mentions - Seeking Alpha|
|View Insider Transactions for ACRX - SECform4.com||View Insider Transactions for ACRX - Insider Cow|
|View ACRX Major Holdings Summary - CNBC||View Insider Disclosure for ACRX - OTC Markets|
|View Insider Transactions for ACRX - Yahoo! Finance||View Institutional Holdings for ACRX - NASDAQ|
|View ACRX Stock Insight & Charts - FinViz.com||View ACRX Investment Charts - StockCharts.com|
|View ACRX Stock Overview & Charts - BarChart||View ACRX User Generated Charts - Trading View|
Concert Pharma's CTP-692 Positive for Schizophrenia in Phase I
Posted on Thursday June 13, 2019
Concert Pharma (CNCE) reports favorable data from the two early-stage studies on its pipeline candidate, CTP-692, currently under evaluation as an adjunctive treatment for schizophrenia. Share rise.
Edited Transcript of ACRX earnings conference call or presentation 8-May-19 8:30pm GMT
Posted on Thursday June 06, 2019
Q1 2019 AcelRx Pharmaceuticals Inc Earnings Call
AcelRx announces the closing of a $25 million senior secured debt facility
Posted on Monday June 03, 2019
REDWOOD CITY, Calif., June 3, 2019 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced the closing of a $25 million senior secured debt facility with Oxford Finance LLC, a specialty finance firm providing senior debt to life sciences and healthcare services companies worldwide. "We are pleased to announce the closing of this debt financing with Oxford," said Vince Angotti, AcelRx Chief Executive Officer.
AcelRx Pharmaceuticals (ACRX) Upgraded to Buy: Here's Why
Posted on Friday May 17, 2019
AcelRx Pharmaceuticals (ACRX) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.